Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool

Journal of the American Academy of Dermatology

Volumn 60, Issue 6, 2009, Pages 1024-1031

  Farley, Elizabeth ^a   Masrour, Shamin ^a   McKey, Joanna ^a   Menter, Alan ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

hand and foot questionnaire; new assessment tool; palmoplantar psoriasis; phenotype; quality of life assessment tool

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; HYDROXYUREA; INFLIXIMAB; METHOTREXATE; PSORALEN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; BODY SURFACE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PHOTOTHERAPY; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; PUVA; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE;

FOOT DERMATOSES; HAND DERMATOSES; HUMANS; PHENOTYPE; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 65649116588     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.11.910     Document Type: Article

References (59)

1. Willian R. On cutaneous diseases. Vol 1. London: J Johnson; 1808.
2. Griffiths C.E., Christophers E., Barker J.N., Chalmers R.J., Chimenti S., Krueger G., et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 156 (2007) 258-262
3. Christophers E. Explaining phenotype heterogeneity in patients with psoriasis. Br J Dermatol 158 (2008) 437-441
4. Burns T., Breathnach S., Cox N., and Griffiths C. Rook's textbook of dermatology (2004), Blackwell Science, Oxford
5. Nickoloff B.J. The immunologic and genetic basis of psoriasis. Arch Dermatol 135 (1999) 1104-1110
6. Kadunce D.P., and Krueger G.G. Pathogenesis of psoriasis. Dermatol Clin 13 (1995) 723-737
7. Lomholt G. On psoriasis. [Danish]. Manedsskr Prakt Laegegern 43 (1965) 177-204
8. Hellgren L. Psoriasis: a statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol 44 (1964) 191-207
9. Kumar B., Saraswat A., and Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 82 (2002) 192-195
10. Corn B.M., Lemont H., and Witkowski J.A. Lesion pattern of psoriasis of the feet: its relationship to the normal weight-bearing force curve. Int J Dermatol 26 (1987) 115-116
11. Kumar B., Kaur I., and Thami G.P. Plantar psoriasis: clinical correlation of lesion pattern to weight bearing. Acta Derm Venereol 75 (1995) 157-158
12. Yiannias J.A., Winkelmann R.K., and Connolly S.M. Contact sensitivities in palmar plantar pustulosis (acropustulosis). Contact Dermatitis 39 (1998) 108-111
13. Mills C.M., Srivastava E.D., Harvey I.M., Swift G.L., Newcombe R.G., Holt P.J., et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 127 (1992) 18-21
14. Guenther L.C. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 11 (2007) 202-205
15. Jacobi A., Schuler G., and Hertl M. Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis. Br J Dermatol 156 (2007) 178-180
16. Schroder K., Zaun H., Holzmann H., Altmeyer P., and el-Gammal S. Pustulosis palmo-plantaris: clinical and histological changes during etretin (acitretin) therapy. Acta Derm Venereol Suppl (Stockh) 146 (1989) 111-116
17. Al-Mutairi N., Joshi A., and Nour-Eldin O. Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare association showing excellent response to acitretin. J Drugs Dermatol 4 (2005) 627-634
18. Ettler K., and Richards B. Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP. Int J Dermatol 40 (2001) 541-542
19. Rivard J., Janiga J., and Lim H.W. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis. J Drugs Dermatol 5 (2006) 505-510
20. Cohen D.J., and Scherschun L. Case reports: practical experience with efalizumab in hand and foot psoriasis. J Drugs Dermatol 6 (2007) 1224-1230
21. Zip C. Treatment of hand and foot psoriasis with emphasis on efalizumab. Skin Therapy Lett 12 (2007) 7-9
22. Roos E.M., Brandsson S., and Karlsson J. Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot Ankle Int 22 (2001) 788-794
23. Martin D.P., Engelberg R., Agel J., Snapp D., and Swiontkowski M.F. Development of a musculoskeletal extremity health status instrument: the musculoskeletal function assessment instrument. J Orthop Res 14 (1996) 173-181
24. Swiontkowski M.F., Engelberg R., Martin D.P., and Agel J. Short musculoskeletal function assessment questionnaire: validity, reliability, and responsiveness. J Bone Joint Surg Am 81 (1999) 1245-1260
25. Budiman-Mak E., Conrad K.J., and Roach K.E. The foot function index: a measure of foot pain and disability. J Clin Epidemiol 44 (1991) 561-570
26. Kitaoka H.B., Alexander I.J., Adelaar R.S., Nunley J.A., Myerson M.S., and Sanders M. Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int 15 (1994) 349-353
27. Hudak P.L., Amadio P.C., and Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand); the upper extremity collaborative group (UECG). Am J Ind Med 29 (1996) 602-608
28. Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., and Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137 (2001) 280-284
29. Crocker H. Diseases of the skin (1888), HK Lewis, London
30. Barber H. Acrodermatitis continua perstans (dermatitis repens) and psoriasis pustulosa. Br J Dermatol 42 (1930) 500-518
31. Ingram J. Acrodermatitis perstans and its relation to psoriasis. Br J Dermatol 42 (1930) 489-499
32. Andrews G. Recalcitrant pustular eruptions of the palms and soles. Arch Dermatol 29 (1934) 548
33. Andrews G. Pustular bacterids of the hands and feet. Arch Dermatol 56 (1935) 766
34. Sachs W.M.G., and Rothstein M.J. Acrodermatitis pustulosa perstans (so-called pustular psoriasis). Arch Dermatol 32 (1947) 766-770
35. Roenigk H. Psoriasis. 3rd ed (1998), Marcel Dekker Inc, New York
36. Ammoury A., El Sayed F., Dhaybi R., and Bazex J. Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venereol 22 (2008) 392-393
37. Asumalahti K., Ameen M., Suomela S., Hagforsen E., Michaelsson G., Evans J., et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 120 (2003) 627-632
38. Kingo K., Mossner R., Koks S., Ratsep R., Kruger U., Vasar E., et al. Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 156 (2007) 646-652
39. Michaelsson G., Kristjansson G., Pihl Lundin I., and Hagforsen E. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol 156 (2007) 659-666
40. James W.D., Berger T.G., and Elston D.M. Andrews' diseases of the skin clinical dermatology. 10th ed (2006), Saunders Elsevier, Canada
41. Abramovits W., Cockerell C., Stevenson L.C., Goldstein A.M., Ehrig T., and Menter A. PsEma-a hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczema. Skinmed 4 (2005) 275-281
42. Takahashi H., Hashimoto Y., Ishida-Yamamoto A., Ashida T., Kohgo Y., and Iizuka H. Psoriasiform and pustular eruption induced by infliximab. J Dermatol 34 (2007) 468-472
43. Starmans-Kool M.J., Peeters H.R., and Houben H.H. Pustular skin lesions in patients treated with infliximab: report of two cases. Rheumatol Int 25 (2005) 550-552
44. Wollina U., Hansel G., Koch A., Schonlebe J., Kostler E., and Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 9 (2008) 1-14
45. Hagforsen E., Awder M., Lefvert A.K., Nordlind K., and Michaelsson G. Palmoplantar pustulosis: an autoimmune disease precipitated by smoking?. Acta Derm Venereol 82 (2002) 341-346
46. Jenisch S., Westphal E., Nair R.P., Stuart P., Voorhees J.J., Christophers E., et al. Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes. Tissue Antigens 53 (1999) 135-146
47. Ashcroft D.M., Wan Po A.L., Williams H.C., and Griffiths C.E. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 141 (1999) 185-191
48. Leary M.R., Rapp S.R., Herbst K.C., Exum M.L., and Feldman S.R. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol 17 (1998) 530-536
49. Finlay A.Y., and Khan G.K. Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (1994) 210-216
50. Gupta M.A., and Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139 (1998) 846-850
51. Finlay A.Y. Quality of life assessments in dermatology. Semin Cutan Med Surg 17 (1998) 291-296
52. McKenna K.E., and Stern R.S. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 34 (1996) 534-538
53. Ashcroft D.M., Li Wan Po A., Williams H.C., and Griffiths C.E. Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 23 (1998) 391-398
54. Feldman S.R., Fleischer A.B., Reboussin D.M., Rapp S.R., Bradham D.D., Exum M.L., et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 37 (1997) 564-569
55. Pettey A.A., Balkrishnan R., Rapp S.R., Fleischer A.B., and Feldman S.R. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 49 (2003) 271-275
56. Lassus A., and Geiger J.M. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol 119 (1988) 755-759
57. White S.I., Marks J.M., and Shuster S. Etretinate in pustular psoriasis of palms and soles. Br J Dermatol 113 (1985) 581-585
58. Ono T., Jono M., Kito M., Tomoda T., Kageshita T., Egawa K., et al. Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris. Acta Otolaryngol Suppl 401 (1983) 12-16
59. Hallberg D., and Molin L. Remission of pustulosis palmaris et plantaris after intestinal shunt operation: reports on three cases. Acta Derm Venereol 54 (1974) 155-156